chrisvoncsefalvay/vaers-outcomes huggingface dataset:
In 2016, she received an injectable flu vaccine (recorded as Afluria, Seqirus).  Within 2 hours of vaccination, she experienced "weak wobbly legs" that interfered with physical training.  Sxms lasted a few days, and resolved without treatment or medical eval.  . In 2017, she received an injectable flu vaccine (recorded as Fluarix, GSK).  Within 2 hours of vaccination, she experienced "weak wobbly legs" as well as back stiffness and aching.  Sxms lasted at least 1 week, and resolved without treatment or medical eval.  . In 2018, she received an injectable flu vaccine (recorded as Fluarix, GSK).  Within 2-3 hours of vaccination, she experienced "weak wobbly legs" and reports that this was the first time she connected the pattern to flu vaccine receipt.  Weakness was more pronounced and included paresthesia/numbness from feet up to knees.  Sxms were accompanied by back pain and stiffnes that was also more intense than previous episodes.  Sxms interfered with activity -- she reports crying while trying to go up steps.  Sxms resolved over approx. 2 weeks.  She did not seek medical care, based on previous bad experiences with medicine - but she now regrets not seeking consult.  2/5/20, Neuro Consult, Dr., MD - ASSESSMENT: Pt's sxs of weakness, numbness and gait instability after receiving flu vaccine suggests an autoimmune reaction directed against her nerves, possibly attachment to the myelin sheath.  She experiences these sxs shortly after vaccination (3-4 days) and lasted up to 3 weeks in duration with last vaccination.   She is back to her baseline now.   With her current presentation of vaccine sensitivity, I would recommend that she be exempt from flu shot prophylaxis in the future due to concerns of possibly developing a more serious condition, such as Guillain-Barre syndrome.   She is not immunocompromised otherwise.    Symptoms: PARESTHESIA OF SKIN(R202), LOW BACK PAIN(M545), WEAKNESS(R531).
early in evening p/vax pt had small tremors of body; also pt would startle & cry out, then have electrical type cycles of movement; eyes did not have the usual look but were different; parents called pvt family practice p/6 episodes;
No additional AEs/no PQCs; HCP reporting that a patient was administered an expired dose of PNEUMOVAX 23 on 01/18/2023. No further information was provided. Consent to contact HCP was provided. No additional AEs/no PQCs.; This spontaneous report has been received from a medical assistant, concerning a patient of unknown age and gender. The patient's medical history, concomitant medications, previous drug reactions, and allergies were not provided.  On 18-JAN-2023, the patient was vaccinated with Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX 23) injection as prophylaxis (lot number U022819 has been verified to be valid; expiration date reported and established as 14-JAN-2023) (expired product administered) (strength, dose, route of administration, and anatomical location were not provided). No additional adverse event was reported.
Patient indicates pain in the area of the arm vaccinated, armpit, burning, swollen and hot. Right arm.
Information has been received from a RN concerning pt with post hospital follow up on iron deficiency, anemia, and recent pneumonia at the time of vaccination. Pt was vaccinated on 10/03/00 and 1 day post vaccination she experienced injection site swelling, redness, and pain radiating to her elbow. Unspecified medical attention was sought. Follow up information indicated that the pt had huge swelling of the area at the site of injection. The pt  also complained of pain. The swelling/edema was noted on the posterior aspect of the elbow.
High blood pressure; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 18Mar2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2, administration date: 17Feb2021, for covid-19 immunisation, reaction(s): "Blood pressure high". The following information was reported: HYPERTENSION (non-serious), outcome "unknown", described as "High blood pressure".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
tinging in ears, dizziness, scalp and ears  wet sensation , yet they are not wet
conjunctivitis and subconjunctival hemmorhage in left eye after smallpox vaccine. Symptoms of eye swelling, pain and copious yellow discharge of the left eye began approximately midnight 7 Feb 03 (day 5). She was treated at civilian ER with antibiotics. Treated with antivirals by physician. As of today drainage and pain have resolved, but redness and swelling persist. Scheduled to follow up on Friday 14 Feb 03 with opthalmology. Follow up states: Pt is now off meds, back at work and recovered. Dx was conjunctivitis and subconjuctivitis hemmorhage in left eye after smallpox vaccine. Annual follow up on 02/26/04: "Pt has recovered from adverse events."
This spontaneous report as received from a registered nurse refers to a patient of unknown age.     On 05-JUL-2017 the patient was vaccinated with and improperly stored dose of LIQUID PEDVAXHIB lot # L051123, expiration date 13-OCT-2018, for prophylaxis. The vaccine was exposed from 32 Fahrenheit degrees (°F) to 35 Fahrenheit degrees (°F) for 45 minutes. There was no previous temperature excursion. The call was made because there was a "data logger"
The next morning I got up to the bathroom and was feeling dizzy. So I laid back down to sleep it off. Then I woke up around 6 am I felt weird and even more dizzy and then I blacked out and woke up on the floor. I got up from the floor and called to go to the hospital; did EKG checked lungs heart beat and blood pressure. Blood pressure and heartbeat was both low. Received IV and slept for a few hours after treatment.
Tightening in my throat, that was eased with Benadryl. Shot area swollen large lump for 3 days. Light-headed. Felt lethargic for Friday, Saturday and Sunday, following the shot on Thursday.
I now have another mild case/Suspected vaccination failure; I now have another mild case; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles. Previously administered products included Shingles vaccine (received Shingles vaccine (original) on an unknown date that was wearing off after 7 years ) and Antiviral (took antiviral to kept shingles to a mild case).   On an unknown date, the patient received the 2nd dose of Shingrix and the 1st dose of Shingrix. In August 2022, unknown after receiving Shingrix and Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. The patient was treated with antivirals nos (Antiviral (Drug Name Unknown)). On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix and Shingrix.     Additional Information: GSK receipt date: 5-Aug-2022 Reporter's comment: The case was received from the patient via interactive digital media. The patient had the shingles even after getting original vaccine that was wearing off after 7 years. The patient took antiviral.to kept them to a mild case.  The patient stated that fast forward to 3 years after getting 2 doses of Shingrix and  now have had another mild case.  The patient began antiviral tonite.  The patient convinced if he/she had not had vaccines they would be much worse. The patient stated that get the shots if you had no allergy to it. Additional supportive information: This case was considered as suspected vaccination failure since the details regarding the time to onset and laboratory confirmation of shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
patient developed an enlarged lymph node at left clavicle.  Also has pain and some swelling under left armpit near breast.    Here is what report said about cyst: EXAM: US SOFT TISSUE NECK HISTORY: Ultrasound of left clavicle area where pt feels palpable mass, possible cyst vs lipoma. TECHNIQUE: Ultrasound images were obtained of the soft tissues of the supraclavicular area in the region of interest. COMPARISON: None available. FINDINGS: Sonographically, no lymph nodes identified in the imaged right supraclavicular region. In the left supraclavicular region, there is a 1.1 x 0.5 cm lymph node. IMPRESSION: Normal-sized short axis lymph node in the region of palpable abnormality. Normal sized lymph node in that area of concern. And you are not having unusual weight loss, fevers, chills or night sweats? If so we can continue to monitor for now and see if it resolves on its own over time (can use heat/ice if painful).
stomach cramps with diarrhea; stomach cramps with diarrhea; mild headache; Achiness; mild fever (100.4),; fatigue; nausea; injection site pain.; This is a spontaneous report from a contactable consumer (patient) or other non hcp. A 66-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EL3248 and expiry date: unknown), dose 1 via an unspecified route of administration, administered in Arm Left on 01Mar2021 at 15:30 as DOSE 1, SINGLE for covid-19 immunisation (age at vaccination: 66-years-old). Medical history included drug hypersensitivity (known allergies: Penicillin). Concomitant medication included omeprazole (OMEPRAZOLE). The patient experienced stomach cramps with diarrhea, mild headache, achiness, mild fever, fatigue, nausea and injection site pain on 01Mar2021 at 16:00. No treatment was received for the events. Outcome of all the events was recovered on an unknown date.  No follow-up attempts are possible; information about lot/batch number cannot been obtained].
I was unable to move my arm for 3 days and I had a headache. My arm stayed sore for 2 weeks. I had issues raising it to get anything from my cabinet. My arm was swollen at the site of the vaccine. I had swollen lymph node under armpit when an ultrasound was completed in April after the 2nd dose (February 25, 2021-Moderna 023M20A) of the vaccine. It showed a swollen lymph node on the left side. Radiologist stated biopsy needed on the breast on the left side. My oncologist indicated she did not like the way the lymph node looked but after biopsy. I was cleared. After the 3rd dose- of vaccine (November 21, 2021), the lymph node was huge so my oncologist had me go to surgery to get the lymph node removed and biopsied. I had to have surgery to have the lymph node removed which was as long as my index finger. The doctor said that there was nothing wrong with the lymph node. After the surgery I went to urgent care because my arm was so swollen that I was not able to put my arm down. I went to the hospital and had another ultrasound done. The doctor indicated that fluid had built up and they may need to go back in. I went to see my doctor after that. I have a big scar and it's still sore under there.
Nausea, vomiting, diarrhea, dizziness, pain at inject. site ( rt deltoid area) starting approx. 5 days /p MMR vaccine given.
Woke up next day with symptoms: Itching, redness and bumps on left leg on upper half of legs and on back of left knee. BENADRYL has relieved her symptoms.
Allergic reaction , hives, close my throat no breathing and a lot itching, all my body red like fire
On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced TENDERNESS (Tenderness), CHILLS (Chills) and LYMPHADENOPATHY (Lymph nodes swelling under the right arm). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] 25-Jan-2021 for Adverse event, at a dose of 500 milligram once a day. At the time of the report, TENDERNESS (Tenderness) and CHILLS (Chills) outcome was unknown and LYMPHADENOPATHY (Lymph nodes swelling under the right arm) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided.
swollen arm; headache; felt sick; This case was reported by a consumer via call center representative and described the occurrence of swelling arm in a elderly female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included flu vaccine with an associated reaction of peripheral swelling (On every October of every year the patient received flu vaccine refer case US2022096941.), flu vaccine with an associated reaction of peripheral swelling (On Oct 2021 the patient received flu vaccine refer case US2022AMR097788.) and Shingrix with an associated reaction of headache (On Dec 2020 the patient received 1st dose of Shingrix refer case US2022AMR097791).   In June 2021, the patient received the 2nd dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced swelling arm, headache and sickness. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the swelling arm, headache and sickness were recovered/resolved.   It was unknown if the reporter considered the swelling arm, headache and sickness to be related to Shingrix.     Linked case(s) involving the same patient:  US2022096941, US2022AMR097788, US2022AMR097791   Additional Information: GSK Receipt Date: 23-JUN-2022 Reporter's Comments: The patient had a swollen arm when she received the Shingrix shot. It was on the same arm where she received the injection.  When the patient received the second dose of Shingrix, she had worse side effects than when receiving the first dose: felt sick, had a headache. The side effects lasted one day. The reporter did not gave consent to follow up. Additional Supportive Information: This is 1 of the 4 cases reported by the reporter.; Sender's Comments:  US-GSKCCFUS-Case-01417054_AE-81514: US-GLAXOSMITHKLINE-US2022096943:Same reporter US-GLAXOSMITHKLINE-US2022AMR097632:Same reporter US-GLAXOSMITHKLINE-US2016018882:Same patient, same reporter US-GLAXOSMITHKLINE-US2022AMR097788:Same patient, same reporter US-GLAXOSMITHKLINE-US2022096941:Same patient, same reporter US-GLAXOSMITHKLINE-US2022AMR097791:Same patient, same reporter US-GLAXOSMITHKLINE-US2022AMR097632:Same reporter US-GLAXOSMITHKLINE-US2022096943:Same reporter
Patient received first dose of Pfizer COVID vaccine on 2/24/21 (lot # EN6198).  Patient reported dizziness/lightheadedness and nausea/vomiting after receiving the vaccines.  No other detail was noted in patient?s MAR.
Patient received Bexsero Meningococcal group B  and not Menquadfi Meningococcal Conjug
Red circle size of a quarter around injection site that is hot. Whole upper arm swollen now with red circle the size of a baseball.
COVID 19; COVID 19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 41-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 13Jun2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 40 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Known allergies penicillin" (unspecified if ongoing), notes: Known allergies penicillin. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Oct2022, outcome "unknown" and all described as "COVID 19". Therapeutic measure taken as a result of drug ineffective, covid-19 included PAXLOVID from 25Oct2022 to 30Oct2022.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Woke up with deeply sore neck muscles, aching joints, headache, light and sound discomfort. Treated with NSAID.
pt recv vax & c/o tightness in chest but did not seek medical care;15NOV98 pt contacted PMD & was seen @ urgent care for labored breathing & tightness of the chest;dx bronchospasm;
On Thursday 8/25/11 I gave a FLUZONE HD flu shot to an 85 y.o. female. On 8/27, in the evening she came to the store with some redness & swelling on her arm around her elbow area. She then saw a doctor regarding her arm, the doctor was not sure if it's related to the flu shot, put her on KEFLEX, and she got better after starting the KEFLEX.
102 degree fever, worst headache ever experienced, chills, nausea, inability to eat, fatigue. all occuring simultaneously from may 10 at 10pm to may 13 at 3pm   at 3pm on may 13 symptoms shifted to extreme dizziness, nausea, and inability to sit, stand or raise arms in lying position without feeling overwhelming sensation of being about to faint or black out. vision tunnels from standing longer than one minute. this is ongoing as of writing this may 14th.
Nurse administered too much vaccine.  Per mother- states that he has fever, headache, soreness in arm, and no appetite.  Mother advised to return to clinic or emergency room if worsening in symptoms.
On 4/13/2022 bright red drop of blood coming from the vagina and went on for 30 hours had to wear pads because the bleeding was really heavy.
Second Dose was Engerix; Initial Report Received on 11-May-2021  A pharmacist reported that a 24 year-old man (race and ethnicity not provided) received the first dose of HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization and Engerix as the second dose of the series.  No relevant medical history was reported.   No relevant concomitant medications were reported.  On an unspecified date in Apr-2021, the patient received the first dose of HEPLISAV-B from a health care professional (Lot #, expiration date, NDC #, route, and site not reported).   On 10-May-2021, about a month after the first dose, the patient came into the pharmacy for the second dose and was given Engerix. It was not realized that the patient received HEPLISAV-B from the health care professional for the first dose until after the second dose (Engerix) was given. No adverse reactions were reported.   No additional information was reported.  Company The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.
Case number PHEH2014US023663 is an initial spontaneous report received from a consumer on 24NOV2014. This report refers to a 72 years old female patient. Her medical history and concomitant medications were not reported. Her vaccination history included administration of two doses of seasonal influenza vaccine (manufacturer and batch number: not reported) which were of 2014/2015 season on unknown dates (see related case number: PHHY2014US156880). She was vaccinated with FLUVIRIN 2014/2015 (seasonal influenza vaccine, batch number: not reported) intramuscularly from a multi-dose vial on 17NOV2014. It was reported that on the same day after vaccination, she experienced cough, sneezing and runny nose. The events outcome was unknown. The seriousness and causality were not reported.
PATIENT REPORTED A HIGH FEVER SOON AFTER RECEIVING VACCINES. FIRST TIME HE HAS EVER GOTTEN A FLU SHOT OR PNEUMO
pt recvd vax; to er approx 17 hrs p/ vax w/ v every 30 mins;was told may be rxn to vax;pt seen in another hosp later in day & was told not a vax rxn;
Red. Swollen, warm at shot site. Became larger in size. Head ache, upset stomach. Took pictures to document swelling and size of red, warm area.
This 48 year-old received his first anthrax vaccination and smallpox revaccination on 17 July 2003.  He reports the anthrax site became sore and red with flu like symptoms, malaise, and generally "feeling bad" for the next few days.  The smallpox site had a good take.  Approximately 3-4 weeks later, after deployed he developed a red-white rash to his lower back that spread below both buttocks.  He describes the rash as initially fine flat pale red-white nonpruritic rash that began at his waist/lower back. This rash spread from his back around the abdomen into his groin and upper thigh, as if he were wearing shorts.   After the rash became white, scaly and crusted it began to itch.  He applied Destin powder to the site as the rash was similar to his experiences with athlete foot.  Within two weeks the rash had dissipated; however whenever he stopped using Destin the rash would reappear within 2-3 days.  He never sought medical care for this disorder.  The rash does not affect any other area of his body.  As of December 22, 2004 the rash is barely visible to his left waist-hip as a fine pale reddened area with white flakes that is non-pruritic.  He reports a history of bilateral athlete foot with onychopathy (onychosis). He also complains of "not feeling 100%" since returning.  He reports two weeks after arriving, he was sick and was advised it was "due to pollution in the air."  He complains of a low grade headache and fever (99 deg F) for the last 1-2 years.  He describes the headache as a 1-2/10 pounding sensation "as if his brain was swollen."  The headache is located over his forehead extending over the top of his head back above the ears.  He does not use any medication for this pain and it resolves on its own.  He is uncertain of time and duration as he just "tolerates it."  He also began to experience periodic chest pain three weeks after arriving  (approximately 6 weeks post smallpox vaccination).  He described the pain as a sharp pain that was in the "pericardium".  The pain began with the onset of a cold, generalized malaise and coughing up light green phlegm.  The pain was nonradiating centered to the left side anteriorly. It worsened with leaning forward and lying down.  It was better sitting upright.  The pain was worse early in the morning. It lasted one week, with periodic reoccurrence depending upon activity performed.  He reports his job consisted of lifting and moving multiple objects with long days of work as a forklift operator.  This pain has persisted intermittently over the last two years with the last pain ten days ago.  He denied any radiating pain, nausea, vomiting, diaphoresis, dizziness or breathing difficulty.  He has not sought medical attention for these complaints.  He is a non-smoker. Of note, he received his Meningiococcal, yellow fever, and typhoid on July 14-15, 2003 and MMR on 7/27/03.
Arm pain and redness, increasing over 3 days, high fever (101.7) and chills occurred next 2 days, near faint sensation, cough, wheezing, pain in left neck.
Initial and follow up information has been received for the Pregnancy Registry for GARDASIL from a registered nurse concerning a 17 year old female with no known significant past medical history or no known concurrent medical condition, who on 14-SEP-2007 was vaccinated with the first dose of GARDASIL (Lot# 6585558/1061U), and was pregnant. On 14_SEP-2007, the patient experienced vaginal candida. Other medications used during the pregnancy was DIFLUCAN for vaginal candida. The patient's estimated LMP was 07-SEP-2007 and had a EDD of 14-JUN-2008. On an unknown date, the pregnancy was confirmed by a pregnancy test. The registered nurse wanted to have the patient added to the pregnancy registry. No further information is available.